Simulations Plus

Drug discovery services partnership with Sino-American Cancer Foundation focuses on the development of actionable hits against the MTHFD2 target…

Promising intellectual property resulting from the collaboration with Polish Academy of Sciences will be jointly owned for further development…

Data sharing partnership will expand chemical coverage space and improve model performance in support of new approach methodologies to ensure…

Simulations Plus, a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, announced the release of…

DSX is faster, more user-friendly, and scalable for high-performance computing Simulations Plus, a leading provider of modeling and simulation…

Ex-Anvisa General Manager will contribute to global regulatory strategies involving pharmacometrics Simulations Plus,, a leading provider of…

Extensive data sharing with large pharmaceutical partner will expand property prediction space and improve model performance. Simulations Plus, Inc.…

DILIsym application contributes to approval of new drugs for migraine treatment Simulations Plus, Inc. , a leading provider of modeling and…

Funded partnership with large pharmaceutical company will enhance mechanistic dissolution models for injectable formulations Simulations Plus,…

SLP will partner with the University of Pittsburgh and its Liver-on-a-Chip platform Simulations Plus, Inc, a leading provider of modeling and…